Natural Health Products Ingredients Database

WHAT'S NEW

What's New is a listing of modifications to the NHPID since the last update. This page was most recently revised on February 18, 2022.

ANNOUNCEMENTS

The updates to the NHPID listed below apply to the most recent version of the web-based Product Licence Application (web PLA) form. All new product licence application submissions must use the web PLA form.


New Ingredients

In this update, the following non-homeopathic ingredients were added.

NHPID Name:
Caricain

Role:
Component


NHPID Name:
Organic Acids

Role:
Component


NHPID Name:
Zingiber Officinale (Ginger) Root Oil

Role:
Non-Medicinal


NHPID Name:
Ginger Oil

Role:
Non-Medicinal


Removed Ingredients

In this update, the following non-homeopathic ingredients were removed.

No Changes.


Revised NHPID Names

In this update, the following non-homeopathic ingredients had their NHPID name revised.

No Changes.


Revised Proper and Common Names

In this update, the following non-homeopathic ingredients had their common or proper names revised.

NHPID Name:
L-Lactic acid

Removed Common Name(s):
(S)-Lactic acid


NHPID Name:
Glycolic acid

Removed Proper Name(s):
Glycolic acid


NHPID Name:
dl-Mandelic acid

Removed Common Name(s):
(+-)-Mandelic acid


NHPID Name:
Ginger Essential Oil

Removed Common Name(s):
Zingiber officinale (Ginger) root oil; Zingiber officinale root oil


NHPID Name:
Oleoresin Ginger

Removed Common Name(s):
Zingiber Officinale (Ginger) Root Oil


New Roles

In this update, the roles of the following non-homeopathic ingredients were changed.

NHPID Name:
Citric acid monohydrate

Old Role:
Medicinal

New Role:
No role


NHPID Name:
Octenidine HCl

Old Role:
Non-Medicinal

New Role:
Non-NHP


NHPID Name:
Ginger Essential Oil

Old Role:
Non-Medicinal

New Role:
No role


Revised Restrictions

In this update, the following non-homeopathic ingredients underwent a modification related to their restrictions.

NHPID Name:
L-Lactic acid

Non-medicinal Restriction(s) changed:
Detail: For skin products, the concentration of alpha-hydroxy acids alone or in combination, when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.


NHPID Name:
Citric acid monohydrate

Non-medicinal Restriction(s) changed:
Detail: For skin products, the concentration of alpha-hydroxy acids alone or in combination, when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.


NHPID Name:
Citric acid

Non-medicinal Restriction(s) changed:
Detail: For skin products, the concentration of alpha-hydroxy acids alone or in combination, when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.


NHPID Name:
Glycolic acid

Non-medicinal Restriction(s) changed:
Detail: For topical use only. For skin products, the concentration of alpha-hydroxy acids alone or in combination, when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.


NHPID Name:
Lactobionic acid

Non-medicinal Restriction(s) changed:
Detail: For topical use only. For skin products, the concentration of alpha-hydroxy acids alone or in combination, when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.


NHPID Name:
Gluconic acid

Non-medicinal Restriction(s) changed:
Detail: For topical use only. For skin products, the concentration of alpha-hydroxy acids alone or in combination, when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.


NHPID Name:
DL-Tartaric acid

Non-medicinal Restriction(s) changed:
Detail: For skin products, the concentration of alpha-hydroxy acids alone or in combination, when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.


NHPID Name:
L-Tartaric acid

Non-medicinal Restriction(s) changed:
Detail: For skin products, the concentration of alpha-hydroxy acids alone or in combination, when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.


NHPID Name:
dl-Mandelic acid

Non-medicinal Restriction(s) changed:
Detail:For topical use only. For skin products, the concentration of alpha-hydroxy acids alone or in combination, when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.


NHPID Name:
D-Malic acid

Non-medicinal Restriction(s) changed:
Detail: For skin products, the concentration of alpha-hydroxy acids alone or in combination, when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.


NHPID Name:
DL-Malic acid

Non-medicinal Restriction(s) changed:
Detail: For skin products, the concentration of alpha-hydroxy acids alone or in combination, when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.


NHPID Name:
L-Malic acid

Route(s) of Adminstration removed:
Topical


NHPID Name:
L-Malic acid

Non-medicinal Restriction(s) changed:
Detail: For skin products, the concentration of alpha-hydroxy acids alone or in combination, when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.


NHPID Name:
L-Malic acid

Non-medicinal Restriction(s) removed:
General


NHPID Name:
DL-Lactic acid

Non-medicinal Restriction(s) changed:
Detail: Do not use in oral products intended for infants less than 3 months old.


NHPID Name:
DL-Lactic acid

New Non-medicinal Restriction(s) added:
General


NHPID Name:
D-Lactic acid

New Non-medicinal Restriction(s) added:
General


NHPID Name:
D-Lactic acid

Non-medicinal Restriction(s) removed:
General


NHPID Name:
D-Lactic acid

Non-medicinal Restriction(s) changed:
Detail: Do not use in oral products intended for infants less than 3 months old.


NHPID Name:
Oleoresin Ginger

Non-medicinal Restriction(s) removed:
General


NHPID Name:
Oleoresin Ginger

Non-medicinal Restriction(s) changed:
Purposes: Flavour Enhancer; Detail:For oral use only.


Other Ingredient Modifications

In this update, the following non-homeopathic ingredients underwent a modification different from those listed above, such as new source material, new preparation type, or new sub-ingredient relationship, etc.

NHPID Name:
Citric acid monohydrate

Modification:
Removed Schedule 1: Isolate


NHPID Name:
Citric acid monohydrate

New Sub-ingredient(s) added:
Citric acid


NHPID Name:
Citric acid

New Source Ingredient(s) added:
Citric acid monohydrate


NHPID Name:
L-Tartaric acid

Modification:
New Oral Allowed Purposes: Effervescent Agent; Flavour Enhancer


NHPID Name:
D-Malic acid

Toxicity Restriction removed:
Detail: An acceptable daily intake (ADI) is not applicable to very young infants, in the case of D(-)-malic acid and its salts.


NHPID Name:
DL-Malic acid

Toxicity Restriction removed:
Detail: Included in the group ADI for malic acid and its sodium, potassium and calcium salts


NHPID Name:
L-Malic acid

Toxicity Restriction removed:
Detail: No safety concern when used as a flavouring agent.


NHPID Name:
Octenidine HCl

New CAS Registry Number(s) added:
70775-75-6


NHPID Name:
Boswellia serrata

New Sub-ingredient(s) added:
Organic Acids


NHPID Name:
Collagen

New Source Material(s) added:
Bos taurus - Bone


NHPID Name:
Bos taurus

New Sub-ingredient(s) added:
Collagen


NHPID Name:
Ginger Essential Oil

Medicinal Rationale changed:
Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations.


NHPID Name:
Oleoresin Ginger

Modification:
Removed Schedule 1: Extract


NHPID Name:
Oleoresin Ginger

Removed NMI purpose(s):
Fragrance Ingredient; Skin-Conditioning Agent


Monograph Modifications

In this update, the following single ingredient or product monographs were added or modified.

Modification:
New monograph: WITCH HAZEL - HAMAMELIS VIRGINIANA Ophthalmic


AbLS Modifications

In this update, the following abbreviated labelling standards were added or modified.

No Changes.


Controlled Vocabulary Modifications

In this update, the following controlled vocabulary (dosage forms, methods of preparation, quality test methods, etc) were added or modified.

No Changes.


Homeopathic Ingredient Modifications

In this update, the following homeopathic ingredients were added or modified.

No Changes.

RemIng

PREVIOUS WHAT'S NEW